QualityStocksNewsBreaks Archives - Page 122 of 1421

MondayAug 12, 2024 10:30 am

Clene Inc.’s (NASDAQ: CLNN) Makes Significant Strides in Developing its Lead Agent, CNM-Au8(R), to Address Neurodegenerative Conditions

Clene has conducted five Phase 2 clinical trials, three with long-term extensions, and three expanded access programs (with additional studies ongoing) to evaluate the safety and efficacy of CNM-Au8 The global ALS treatment market is poised for growth, driven by an aging population and limited current treatment options CNM-Au8 works by improving cellular energy production and utilization, which is crucial for maintaining neuronal health, and is at a deficit in neurodegenerative diseases Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc. is a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative…

MondayAug 12, 2024 9:12 am

QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Shareholders Approve Plans for Share Consolidation, Name Change

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is planning to consolidate its issued and outstanding class A multiple voting shares and class B subordinate voting shares. The company also has announced a planned name change to Quantum BioPharma Ltd, with a new trading symbol of QNTM. The consolidation, which is part of the company’s efforts to regain compliance with NASDAQ’s minimum bid price, and name change are subject to approval by the NASDAQ exchange; if approved, the changes will be effective Aug. 15, 2024. These…

FridayAug 09, 2024 2:07 pm

QualityStocksNewsBreaks – FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) Reports on Status of New Product, Investment in Celly Nutrition Corp.

FSD Pharma (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions, is providing a status report on its investment in Celly Nutrition Corp. A privately held Canadian company, Celly Nu is launching an innovative beverage product designed to assist in expediting alcohol metabolism and faster recovery from alcohol consumption. According to the update, Celly Nu has announced the imminent launch of its revolutionary, great-tasting, scientifically backed product, unbuzzd(TM). The product will be available in 3-pack or 18-pack options, and the compact packages can easily be carried in a pocket…

FridayAug 09, 2024 1:56 pm

QualityStocksNewsBreaks – Alphabet Inc. (NASDAQ: GOOGL) Faces Antitrust Scrutiny Amid Market Dominance

Alphabet (NASDAQ: GOOGL, GOOG), the parent company of Google, is currently facing a challenging period, with antitrust scrutiny at the forefront of its concerns. Despite the complexities surrounding the antitrust ruling, experts from Barron’s suggest that Google’s market dominance is unlikely to be significantly impacted by the label of being a monopolist. However, it’s important to note that other risks loom large, potentially threatening the tech giant’s position. The recent performance of Alphabet Inc.’s stock reflects the company’s current challenges and investor sentiment. With a closing price of $159.89, down $2.15 or -1.32%, the market is reacting to the ongoing developments. The stock’s movement…

ThursdayAug 08, 2024 12:21 pm

QualityStocksNewsBreaks – MetAlert Inc. (MLRT) Selects TEAL to Support Rollout of Its GunAlert and SmartSole Products

MetAlert (OTC: MLRT), a pioneer in the field of wearable GPS human and high value asset tracking, today announced a partnership with TEAL. According to the announcement, the partnership is a critical component for the launch of MetAlert’s GunAlert(R) as well as the global rollout of its GPS SmartSole(TM) plus. TEAL will provide its advanced connectivity solutions and secure protocol for the GunAlert platform, an all-in-one gun safety combination lock with integrated motion sensor and GPS theft recovery technology, and the award-winning GPS SmartSole(TM), a wearable medical monitoring device that is integrated into an orthotic insole allowing discreet and unobtrusive…

WednesdayAug 07, 2024 10:24 am

QualityStocksNewsBreaks – Bebuzee Inc. (BBUZ) Announces ‘Milestone’ Launch of SuperApp Designed to Change Users’ Interaction with Digital Services

Bebuzee (OTC: BBUZ), a pioneering force in the realm of social technology, has unveiled a new SuperApp designed to transform the way users interact with technology. According to the announcement, the new app, which will be available Aug. 30, 2024, offers an extensive array of features in a single, seamless platform. Those features include video streaming, photo sharing, instant messaging, short-form videos, global real estate search and e-commerce capabilities. The company noted that the new app opens unprecedented revenue opportunities. With potential in a wide array of markets, including video ads, sponsored posts, premium subscriptions and more, the app will…

TuesdayAug 06, 2024 2:03 pm

QualityStocksNewsBreaks – Finovate Shares FinovateFall Agenda Highlights

Finovate, a research and events company focused on innovation in financial and banking technology, is hosting FinovateFall, a pioneering fintech conference focused on the digital future of financial institutions. The event is slated for Sept. 9–11, 2024, in New York City. According to the announcement, the three-day fintech conference is “by and for executives and thought leaders who are revolutionizing the financial services industry.” The event agenda includes presentations from more than 120 renowned speakers and subject matter experts and more than 60-plus live product demonstrations from a range of fintech companies, including startups to established players. Speakers for the…

TuesdayAug 06, 2024 11:34 am

QualityStocksNewsBreaks – Blockchain Futurist Conference Plays Pivotal Role in Shaping the Future of Web3, Finance

Blockchain Futurist Conference is Canada’s largest and most high-profile Web3, blockchain and cryptocurrency event. Serving as an essential platform for ideas and collaboration, the conference has proven to be an important global gathering helping shape the future of Web3. This year’s event is scheduled for August 13-14, 2024, in Toronto, Canada; the event will run alongside ETHToronto and ETHWomen Hackathons, the largest web3 hackathons in Canada. During Futurist 2023, reporter Daniel Bruno solicited quotes from onsite attendees experiencing the excitement of the event. What they said sets the tone for this year’s dynamic must-attend Blockchain Futurist Conference. “We have attended…

TuesdayAug 06, 2024 11:12 am

QualityStocksNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Reports on Clinical Data Showing Lead Compound Combined with GLP-1 Agonist Enhances Cognition

Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s disease (“AD”) and Parkinson’s disease (“PD”), is reporting preclinical data regarding its lead compound, buntanetap. According to the announcement, the results show the synergistic effect of buntanetap when combined with the glucagon-like peptide 1 (“GLP-1”) agonist dulaglutide (Trulicity[R]) in a mouse model of Alzheimer’s disease. Based on data gathered in 2018 showing that buntanetap fully restored memory, learning and synaptic potentiation in an Alzheimer’s mouse model, Annovis recently studied whether buntanetap combined with the GLP-1 agonist dulaglutide produced a synergistic effect in the…

TuesdayAug 06, 2024 10:10 am

QualityStocksNewsBreaks – Ocugen Inc. (NASDAQ: OCGN) Closes on $35M Public Offering

Ocugen (NASDAQ: OCGN), a biotechnology company focused on discovering, developing and commercializing novel gene and cell therapies and vaccines, has closed on its previously announced underwritten public offering. The offering was comprised of 30,434,783 shares of its common stock, with each share sold at $1.15 per share. The company is anticipated to receive an estimated $35 million in gross proceeds, before standard deductions and expenses are made. Ocugen plans to use the funds from the offering for general corporate purposes, capital expenditures, working capital, and general and administrative expenses. Titan Partners Group, a division of American Capital Partners, acted as…

Site Search

Company Search

Category: QualityStocksNewsBreaks